Surgery Partners shares receive ‘buy’ rating: 5 quick facts

Analysts gave Surgery Partners’ shares a consensus rating of “buy,” according to Financial Market News.

Advertisement

Here are five quick facts:

1. Analysts have an average one-year price target of $23.55.

2. On Jan. 29, Surgery Partners’ shares opened at $16.65.

3. The company has a 52-week high of $22.32 and 52-week low of $15.11.

4. The shares have a 50-day moving average of $18.65 and 200-day moving average of $18.73.

5. The market cap is $801.8 million.

More articles on surgery centers:
Nobilis Health CEO acquires 10k company shares: 3 insights
St. Vincent’s One Nineteen completes 1st surgery in outpatient center: 4 things to know
Mizuho raises HCA price objective to $102: 5 quick notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • Atlanta-based United Digestive is planning an ASC in Watkinsville, Ga., focusing on organic growth to expand its network. The newly-constructed,…

  • At least 25 ASCs have closed over the past five years, a pattern of attrition driven by financial strain, staffing…

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

Advertisement

Comments are closed.